StockNews.com Begins Coverage on China Pharma (NYSE:CPHI)

StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHIFree Report) in a research report report published on Sunday morning. The brokerage issued a hold rating on the stock.

China Pharma Trading Down 9.9 %

Shares of NYSE CPHI opened at $0.22 on Friday. The business has a 50 day simple moving average of $0.20 and a 200 day simple moving average of $0.21. China Pharma has a 52 week low of $0.13 and a 52 week high of $0.60. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26.

China Pharma Company Profile

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Featured Articles

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.